Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA® (olaparib) demonstrated sustained, clinically ...

LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial ...

ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stage MONT-SAINT-GUIBERT, Belgium, Dec. 11, 2024 (GLOBE NEWSWIRE) -- EsoBiotec SA, a biotechnology company empowering cells in ...

Rising blood levels of inflammatory marker neutrophil-to-lymphocyte ratio are linked to poorer outcomes with chronic kidney ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

AbbVie (ABBV) announced updated results from the Phase 1b/2 EPCORE NHL-2 trial evaluating fixed-duration investigational epcoritamab, ...

Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...

In a recent article, researchers explored how calcium carbonate nanoparticles enhance T cell activation through calcium ...

A study was conducted to determine the prognostic impact of neutrophil-to-lymphocyte ratio in patients receiving PCI who do and do not have diabetes.

Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...

The following is a summary of “Effect of hemoglobin, albumin, lymphocyte, and platelet score on prognosis in ...

Elevated levels of the toxic heavy metal have been detected in treated water sourced from the Waikato River, authorities revealed yesterday. The Water Services Authority, Taumata Arowai ...